GenetiSure Cancer and Postnatal Arrays

Whether you are studying cancer or performing postnatal research, Agilent has the CGH+SNP design for a successful experiment. The GenetiSure Cancer Research CGH+SNP microarray is designed to target cancer regions of the genome sourced from the COSMIC and CGC databases. Loss of heterozygosity (LOH) detection, with a resolution validated to 2.5 Mb, ensures that important aberrations are not missed. While the GenetiSure postnatal research array allows simultaneous detection of copy number changes and copy neutral aberrations down to 2.5 Mb. Through the inclusion of exon-centric probes, the detection of aberrations associated with intellectual disability and congenital anomalies is maximized.